SCHEMBL3688534

SCHEMBL3688534

CC(=O)Nc1ccc(NC(=O)c2c(F)ccc([AsH]S(=O)(=O)N3CCOCC3)c2F)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
BRAF P15056 2/20 0.40
KMT2A Q03164 5/20 0.40
MEN1 O00255 2/20 0.40
MTOR P42345 1/20 0.39
MAPK1 P28482 2/20 0.39
LMNA P02545 2/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 1/20 0.38
DGAT1 O75907 1/20 0.38
BRD4 O60885 1/20 0.37
BRD3 Q15059 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL287461 0.83 BRAF (0.54) NPC1RAB9ABRAF
SCHEMBL16161987 0.76 RAB9A (0.46) NPC1RAB9AKCNQ3KCNQ2BRAF
SCHEMBL3029038 0.75 BRAF (0.64) BRAFKMT2AMEN1
SCHEMBL288143 0.74 BRAF (0.58) BRAF
SCHEMBL3019469 0.74 BRAF (0.63) BRAFKMT2AMEN1
SCHEMBL16274000 0.73 KMT2A (0.52) NPC1RAB9AKCNQ3KCNQ2BRAF
SCHEMBL288303 0.72 KMT2A (0.51) NPC1RAB9AKCNQ3KCNQ2BRAF
SCHEMBL16162140 0.71 NPC1 (0.40) NPC1RAB9AKCNQ3KCNQ2BRAF
SCHEMBL13271114 0.71 KMT2A (0.52) NPC1RAB9AKCNQ3KCNQ2BRAF
SCHEMBL287979 0.70 BRAF (0.63) BRAFKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170830-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2010-04-07 EP disclosed
WO-2009012283-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2009-01-22 WO disclosed